Biernacki, M. A., Foster, K. A., Woodward, K. B., Coon, M. E., Cummings, C., Cunningham, T. M., . . . Bleakley, M. (2020). CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia. J Clin Invest.
Chicago Style citaatBiernacki, Melinda A., et al. "CBFB-MYH11 Fusion Neoantigen Enables T Cell Recognition and Killing of Acute Myeloid Leukemia." J Clin Invest 2020.
MLA citatieBiernacki, Melinda A., et al. "CBFB-MYH11 Fusion Neoantigen Enables T Cell Recognition and Killing of Acute Myeloid Leukemia." J Clin Invest 2020.
Let op: Deze citaties zijn niet altijd 100% accuraat.